期刊论文详细信息
Trials
Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial
Nicholas Freemantle6  Emma Frew3  Andrew Ball2  Sanju George4  Charlotte Powell2  Deborah Bamber2  Marilyn Christie2  Jennifer L Seddon1  Alex Copello1  Edward Day5 
[1]School of Psychology, The University of Birmingham, Birmingham B15 2TT, UK
[2]Leicester City Drug & Alcohol Service, Paget House, 2 West Street, Leicester LE1 6XP, UK
[3]Health Economics, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
[4]Birmingham & Solihull Mental Health Foundation Trust, Research & Innovation Department, Radclyffe House, 66-68 Hagley Road, Birmingham B16 8PF, UK
[5]Addictions Department, National Addiction Centre, Addiction Sciences Building, 4 Windsor Walk, Denmark Hill, London SE5 8AF, UK
[6]Department of Primary Care and Population Health, Upper Third Floor, UCL Medical School (Royal Free Campus), Rowland Hill Street, London NW3 2PF, UK
关键词: Heroin use;    Social behavior and network therapy (SBNT);    Social networks;    Randomized controlled trial;   
Others  :  1093207
DOI  :  10.1186/1745-6215-14-264
 received in 2013-02-28, accepted in 2013-08-06,  发布年份 2013
PDF
【 摘 要 】

Background

Research indicates that 3% of people receiving opiate substitution treatment (OST) in the UK manage to achieve abstinence from all prescribed and illicit drugs within 3 years of commencing treatment, and there is concern that treatment services have become skilled at engaging people but not at helping them to enter a stage of recovery and drug abstinence. The National Treatment Agency for Substance Misuse recommends the involvement of families and wider social networks in supporting drug users’ psychological treatment, and this pilot randomized controlled trial aims to evaluate the impact of a social network-focused intervention for patients receiving OST.

Methods and design

In this two-site, early phase, randomized controlled trial, a total of 120 patients receiving OST will be recruited and randomized to receive one of three treatments: 1) Brief Social Behavior and Network Therapy (B-SBNT), 2) Personal Goal Setting (PGS) or 3) treatment as usual. Randomization will take place following baseline assessment. Participants allocated to receive B-SBNT or PGS will continue to receive the same treatment that is routinely provided by drug treatment services, plus four additional sessions of either intervention. Outcomes will be assessed at baseline, 3 and 12 months. The primary outcome will be assessment of illicit heroin use, measured by both urinary analysis and self-report. Secondary outcomes involve assessment of dependence, psychological symptoms, social satisfaction, motivation to change, quality of life and therapeutic engagement. Family members (n = 120) of patients involved in the trial will also be assessed to measure the level of symptoms, coping and the impact of the addiction problem on the family member at baseline, 3 and 12 months.

Discussion

This study will provide experimental data regarding the feasibility and efficacy of implementing a social network intervention within routine drug treatment services in the UK National Health Service. The study will explore the impact of the intervention on both patients receiving drug treatment and their family members.

Trial registration

Trial Registration Number: ISRCTN22608399

ISRCTN22608399 registration: 27/04/2012

Date of first randomisation: 14/08/2012

【 授权许可】

   
2013 Day et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150130161312377.pdf 655KB PDF download
Figure 1. 90KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Davies C, English L, Stewart C, Lodwick A, McVeigh J, Bellis MA: United Kingdom Drug Situation: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2011. London: UK Focal Point at the Department of Health; 2011.
  • [2]Best D, George S, Day E: The development of the drug treatment system in England. In Clinical Topics in Addiction. Edited by Day E. London: RCPsych; 2007:14-28.
  • [3]HM Government: Drug Strategy 2010. Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life. London: Home Office; 2010:2010.
  • [4]McKeganey N, Bloor M, Robertson M, Neale J, MacDougall J: Abstinence and drug abuse treatment: results from the drug outcome research in Scotland study. Drugs: Education, Prevention and Policy 2006, 13:537-550.
  • [5]Drummond DC, Kouimtsidis C, Reynolds M, Russell I, Godfrey C, McCusker M, Coulton S, Parrott S, Davis P, Tarrier N, Turkington D, Sell L, Merrill J, Williams H, Abou-Saleh M, Ghodse H, Porter S, Daw R, Fyles N, Keating S, Moloney A, Pryce K, Mehdikhani M, Barnaby B, Leach J, Ruben S, UKCBTMM Project Group: The Effectiveness and Cost Effectiveness of Cognitive Behaviour Therapy for Opiate Misusers in Methadone Maintenance Treatment: a Multicentre Randomised Controlled Trial (UKCBTMM). Final Report to the Department of Health Research and Development Directorate. London: Department of Health; 2004.
  • [6]Best D, Hernando R, Gossop M, Sidwell C, Strang J: Getting by with a little help from your friends. The impact of peer networks on criminality in a cohort of treatment-seeking drug users. Addictive Behaviours 2003, 28:597-603.
  • [7]Gogineni A, Stein M, Friedmann PD: Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend 2001, 64:47-53.
  • [8]Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, Knowlton A: Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend 1995, 38:1-9.
  • [9]Schroeder JR, Latkin CA, Hoover DR, Curry AD, Knowlton AR, Celentano DD: Illicit drug use in one’s social network and in one’s neighbourhood predicts individual heroin and cocaine use. Ann Epidemiol 2001, 11:389-394.
  • [10]Cohen S, Lichtenstein E: Partner behaviours that support quitting smoking. J Consult Clin Psychol 1990, 58:304-309.
  • [11]Goehl L, Nunes E, Quitkin F, Hilton I: Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abuse 1993, 19:251-262.
  • [12]Havassy BE, Wasserman DA, Hall SM: Social relationships and abstinence from cocaine in an American treatment sample. Addiction 1995, 90:699-710.
  • [13]Wasserman DA, Stewart AL, Delucchi KL: Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug Alcohol Depend 2001, 65:65-75.
  • [14]Zywiak WH, Neighbors CJ, Martin RA, Johnson JE, Eaton CA, Rohsenow DJ: The important people drug and alcohol interview: psychometric properties, predictive validity, and implications for treatment. J Subst Abuse Treat 2009, 36:321-330.
  • [15]Copello A, Templeton L, Powell J: Adult Family Members and Carers of Dependent Drug Users: Prevalence, Social Cost, Resource Savings and Treatment Responses. London: UK Drug Policy Commission; 2009.
  • [16]National Treatment Agency for Substance Misuse: NTA Policy on Involvement of Users and Family Members. London: NTA; 2008.
  • [17]The Centre for Social Justice: Green Paper on Criminal Justice and Addiction. London: The Centre for Social Justice; 2010.
  • [18]National Treatment Agency for Substance Misuse: NTA Business Plan 2010–11. London: NTA; 2010.
  • [19]The Betty Ford Institute Consensus Panel: What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 2007, 33:221-228.
  • [20]Copello A, Orford J, Hodgson R, Tober G, Barrett C: Social behaviour and network therapy - basic principles and early experiences. Addictive Behaviours 2002, 27:345-366.
  • [21]UKATT Research Team: Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 2005, 331:541-544.
  • [22]UKATT Research Team: Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 2005, 331:544-548.
  • [23]Copello A, Williamson E, Orford J, Day E: Implementing and evaluating social behaviour and network therapy in drug treatment practice in the UK: a feasibility study. Addict Behav 2006, 31:802-810.
  • [24]Dale V, Coulton S, Godfrey C, Copello A, Hodgson R, Heather N, Orford J, Raistrick D, Slegg G, Tober G, on behalf of the UKATT Research Team: Exploring treatment attendance and its relationship to outcome in a randomized controlled trial of treatment for alcohol problems: secondary analysis of the UK alcohol treatment trial (UKATT). Alcohol Alcohol 2011, 46:592-599.
  • [25]Ray GT, Mertens JR, Weisner C: Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma. Addiction 2009, 104:203-214.
  • [26]Schulz KF, Altman DG, Moher D, Group ftC: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332.
  • [27]Day E, Best D, Bartholomew NG, Dansereau DF, Simpson DD: The BTEI Care Planning Manual: Mapping Achievable Goals. In Routes to Recovery. London: National Treatment Agency for Substance Misuse; 2009.
  • [28]Dansereau DF, Simpson DD: A picture is worth a thousand words: the case for graphic representations. Professional Psychology: Research and Practice 2009, 40:104-110.
  • [29]Best D, Day E, Morgan B, Oza T, Copello A, Gossop M: What treatment means in practice: an analysis of the delivery of evidence-based structured interventions in criminal justice drug treatment services in Birmingham. England Addiction Research and Theory 2009, 17:678-687.
  • [30]Tober G, Clyne W, Finnegan O, Farrin A, Russell I, UKATT Research Team: Validation of a scale for rating the delivery of psycho-social treatments for alcohol dependence and misuse: The UKATT Process Rating Scale (PRS). Alcohol & Alcoholism 2008, 43:675-682.
  • [31]Marsden J, Farrell M, Bradbury C, Dale-Perera A, Eastwood B, Roxborough M, Taylor S: Development of the treatment outcomes profile. Addiction 2008, 103:1450-1460.
  • [32]Pocock SJ: Clinical Trials: A Practical Approach. Chichester: John Wiley & Sons; 1983.
  • [33]Marsden J, Gossop M, Stewart D, Best D, Farrell M, Strang J: The Maudsley Addiction Profile: Development and User Manual. London: National Addiction Centre/Institute of Psychiatry; 1998.
  • [34]Raistrick D, Bradshaw J, Tober G, Weiner J, Allison J, Healey C: Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction 1994, 89:563-572.
  • [35]Evans C, Connell J, Barkham M, Margison F, McGrath G, Mellor-Clark J, Audin K: Towards a standardized brief outcome measure: psychometric properties and utility of the CORE-OM. Br J Psychiat 2002, 180:51-60.
  • [36]Raistrick D, Tober G, Heather N, Clark JA: Validation of the Social Satisfaction Questionnaire for outcome evaluation in substance use disorders. Psychiatric Bulletin 2007, 31:333-336.
  • [37]Heather N, Luce A, Peck D, Dunbar B, James I: Development of a treatment version of the Readiness to Change Questionnaire. Addiction Research 1999, 7:63-83.
  • [38]Prochaska JO, DiClemente CC: Transtheoretical therapy: toward a more integrative model of change. Psychotherapy: Theory Research and Practice 1982, 19:276-288.
  • [39]Cohen S, Mermelstein R, Kamarck T, Hoberman HM: Measuring the functional components of social support. In Measuring the Functional Components of Social Support. Edited by Sarason IG, Sarason BR. London: Springer; 1985:73-94.
  • [40]Joe GW, Broome KM, Rowan-Szal GA, Simpson DD: Measuring patient attributes and engagement in treatment. J Subst Abuse Treat 2002, 22:183-196.
  • [41]Orford J, Templeton L, Velleman R, Copello A: Family members of relatives with alcohol, drug and gambling problems: a set of standardized questionnaires for assessing stress, coping and strain. Addiction 2005, 100:1611-1624.
  • [42]Al-Janabi H, Flynn TN, Coast J: Development of a self-report measure of capability wellbeing for adults: the ICECAP-A. Qual Life Res 2011, 21:167-176.
  • [43]The EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
  • [44]Beecham J, Knapp M: Costing psychiatric interventions. In Measuring Mental Health Needs. Edited by Thornicroft G, Brewin C, Wing J. London: Gaskell; 1992:163-183.
  • [45]SAS Institute Inc: Chapter 6: Introduction to mixed modelling procedures. In SAS/STAT 92 User’s Guide (second Edition). Cary, NC: SAS Institute Inc; 2009:127-140.
  • [46]Williamson E, Smith M, Orford J, Copello A, Day E: Social behaviour and network therapy for drug problems: evidence of benefits and challenges. Addictive Disorders and Their Treatment 2007, 6:167-179.
  • [47]Braun V, Clarke V: Using thematic analysis in psychology. Qualitative Research in Psychology 2006, 3:77-101.
  • [48]Briggs A, Sculpher M, Claxton C: Decision Modelling for Economic Evaluation. Oxford: Oxford University Press; 2006.
  • [49]Walker D, Fox-Rushby J: Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis. Health Policy Plan 2001, 16:435-443.
  • [50]National Collaborating Centre for Mental Health: Drug Misuse: Psychosocial Interventions. London: British Psychological Society & The Royal College of Psychiatrists; 2008.
  文献评价指标  
  下载次数:0次 浏览次数:5次